Folic Acid vs 5-MTHF in Pregnancy: What the Science Actually Shows

By Nikki Warren, Fertility Naturopath & Founder of NaturoBest

If you’ve spent any time on Reddit or pregnancy forums lately, you may have seen statements like:

“Don’t fall for the 5-MTHF hype. Folic acid is the only form proven to reduce neural tube defects.”

I understand why this argument sounds convincing. But it leaves out critical scientific, ethical, and biochemical context.

As a fertility naturopath for over a decade, and now as the founder of a prenatal supplement company, I want to walk you through what the evidence actually shows, what it can’t show for ethical reasons, and where 5-MTHF genuinely demonstrates advantages beyond neural tube defect prevention.

This is not about hype. It’s about understanding how folate works in the body.

Why folic acid has “proof” for neural tube defects and 5-MTHF doesn’t

It is true that folic acid has large randomised controlled trials (RCTs) showing a reduction in neural tube defects (NTDs). This evidence underpins public health policies worldwide, including food fortification.

What is often not explained is why the same type of trials do not exist for 5-MTHF.

The ethical reality

Once folic acid was shown to reduce NTDs, it became unethical to design a study where pregnant women are deliberately denied an effective intervention.

To prove 5-MTHF “directly” reduces NTDs in the same way would require:

1. One group receiving folic acid

2. Another group receiving no proven equivalent

That would knowingly place some pregnancies at increased risk. Ethics committees will not approve this.

This is not a scientific weakness of 5-MTHF. It is a consequence of existing success.

The biochemical reality Reddit leaves out

Folic acid is not biologically active.

It must be converted through several enzymatic steps before becoming 5-methyltetrahydrofolate (5-MTHF) – the form that:

1. Crosses the placenta

2. Participates in DNA synthesis

3. Supports methylation

4. Is used by the developing neural tube

In other words:

All folic acid must become 5-MTHF to work.

This is not theory. This is established folate metabolism.

If folic acid reduces neural tube defects, it does so only after conversion into 5-MTHF.

That is why many researchers have asked the logical question:

If 5-MTHF is the biologically active form, could it achieve the same outcome more efficiently or more reliably?

What human studies actually show about 5-MTHF and folate status

Multiple human studies comparing folic acid and 5-MTHF show that 5-MTHF is:

1. At least as effective at raising plasma folate

2. Often superior at increasing red blood cell (RBC) folate

3. Effective regardless of MTHFR genotype

Higher RBC folate levels are strongly associated with lower neural tube defect risk.

A large decision-analytic model using real human folate data estimated that women using Metafolin® (a calcium salt of 5-MTHF) could experience a 23–31% reduction in predicted neural tube defect risk, based on achieved RBC folate levels .

This is not a clinical trial in pregnancy for ethical reasons.

It is the next best level of evidence available.

The Reddit myth: “5-MTHF is just marketing”

This claim ignores where 5-MTHF actually shows clear clinical superiority.

Recurrent miscarriage and fertility outcomes

A well-published case series in couples with recurrent miscarriage and infertility, many of whom carried MTHFR polymorphisms, compared outcomes after switching from high-dose folic acid to 5-MTHF as Quatrefolic®.

Key findings:

1. Most women had failed previous treatment with 5 mg folic acid

2. Supplementation with 800 mcg of 5-MTHF (Quatrefolic®) resulted in:

3. 13 spontaneous pregnancies

4. 13 additional pregnancies via ART

5. An overall ongoing pregnancy rate of 86.7%

The authors concluded that the conventional use of high-dose folic acid in this population had become obsolete, and that 5-MTHF bypasses metabolic blocks associated with MTHFR polymorphisms.

This is not marketing language.

This is peer-reviewed reproductive medicine.

What about unmetabolised folic acid (UMFA)?

Excess folic acid intake can lead to unmetabolised folic acid (UMFA) circulating in the bloodstream, particularly in individuals with reduced enzymatic capacity.

UMFA has been associated in observational research with:

1. Impaired immune function

2. Altered folate transport

3. Potential interference with normal methylation pathways

4. 5-MTHF does not contribute to UMFA because it does not require enzymatic reduction before entering circulation.

This distinction matters most in:

1. Women with MTHFR polymorphisms

2. Those using higher supplemental doses

3. Long-term preconception supplementation

So why do some companies insist only folic acid “counts”?

In my opinion (and this is opinion), this argument often serves:

1. Regulatory simplicity

2. Legacy positioning

3. Commercial defensiveness

Folic acid has historical dominance because it was first, cheap, stable, and easy to fortify.

But absence of identical trial design is not absence of biological effect.

The balanced truth women deserve

Here is the most accurate statement I can make:

1. Folic acid is proven to reduce neural tube defects

2. 5-MTHF is the biologically active form responsible for that effect

3. It is unethical to run placebo-controlled NTD trials with 5-MTHF

4. Human data show 5-MTHF reliably achieves protective folate levels

5. 5-MTHF (Quatrefolic®) shows clear advantages in fertility and recurrent miscarriage

6. Choice of folate form should consider individual metabolism, not marketing slogans

Women deserve more than Reddit soundbites. They deserve nuance.